Medexus Pharma 2

Medexus Pharma Revenue and Profits Surge on Acquisitions

Brendan Byrne - July 8, 2019

Following Monday's closing bell, Canadian specialty pharma company Medexus Pharmaceuticals (TSX-V:MDP)(OTCQB:PDDPF) released its results from operations for the quarter and fiscal year ended March 31, 2019 showing a dramatic improvement...

Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Donna Fago - June 4, 2019

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older....

Sign Up To Get Our Latest Stocks Alerts